Disclosure 0001213900-26-109160-3

SEC FORM 4

—

Retension Pharmaceuticals, Inc. (RTSN)

Acquisition (code C) of 31,368 shares; price not stated (see filing).

Reporting Person Keller Eric L. · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code C

Traded Oct 13, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001213900-26-109160 · filed 2026-10-13 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Retension Pharmaceuticals, Inc. (RTSN)." Disclosed 2026-10-13. https://desqlong.com/cards/0001213900-26-109160-3 (retrieved 2026-10-14).